The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds
Clinical trial NCT01153620 · COMPLETED
Trial details
- NCT number
- NCT01153620
- Sponsor
- B. Braun Ltd. Centre of Excellence Infection Control
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-01-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.